Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
Fri, 22nd Jul 2011 14:18
(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.
Read more(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.
Read more
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:
Read more(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.
Read more(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.
Read more(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.
Read more(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.
Read more(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.
Read more(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.
Read more(Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times
Read more(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.
Read more(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC.
Read more(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US.
Read more| Friday 6 October | |
| Admiral Group PLC | dividend payment date |
| Alfa Financial Software Holdings PLC | special dividend payment date |
| Anglo-Eastern Plantations PLC | dividend payment date |
| Blackrock World Mining Trust PLC | dividend payment date |
| Cairn Homes PLC | dividend payment date |
| Dalata Hotel Group PLC | dividend payment date |
| Drax Group PLC | dividend payment date |
| Glanbia PLC | dividend payment date |
| GlobalData PLC | dividend payment date |
| Goodwin PLC | dividend payment date |
| Greggs PLC | dividend payment date |
| Intertek Group PLC | dividend payment date |
| Irish Continental Group PLC | dividend payment date |
| JPMorgan American Investment Trust PLC | dividend payment date |
| JPMorgan Global Growth & Income PLC | dividend payment date |
| Land Securities Group PLC | dividend payment date |
| Personal Assets Trust PLC | dividend payment date |
| Quartix Technologies PLC | dividend payment date |
| Serco Group PLC | dividend payment date |
| Walker Crips Group PLC | dividend payment date |
| Warehouse REIT PLC | dividend payment date |
| Zotefoams PLC | dividend payment date |
| Monday 9 October | |
| Henderson Smaller Cos Investment Trust PLC | dividend payment date |
| LondonMetric Property PLC | dividend payment date |
| Tuesday 10 October | |
| LSL Property Services PLC | dividend payment date |
| Wednesday 11 October | |
| Assura PLC | dividend payment date |
| Rathbones Group PLC | dividend payment date |
| Thursday 12 October | |
| Blackrock Latin American Investment Trust PLC | ex-dividend payment date |
| Breedon Group PLC | ex-dividend payment date |
| Diageo PLC | dividend payment date |
| GSK PLC | dividend payment date |
| Howden Joinery Group PLC | ex-dividend payment date |
| i3 Energy PLC | ex-dividend payment date |
| Invesco Bond Income Plus Ltd | ex-dividend payment date |
| JPMorgan Asia Growth & Income PLC | ex-dividend payment date |
| JPMorgan Mid Cap Investment Trust PLC | ex-dividend payment date |
| Kingfisher PLC | ex-dividend payment date |
| MP Evans Group PLC | ex-dividend payment date |
| Macfarlane Group PLC | dividend payment date |
| North American Income Trust PLC | ex-dividend payment date |
| Oxford Instruments PLC | dividend payment date |
| Persimmon PLC | ex-dividend payment date |
| Personal Group Holdings PLC | ex-dividend payment date |
| Primary Health Properties PLC | ex-dividend payment date |
| Ruffer Investment Co Ltd | ex-dividend payment date |
| Senior PLC | ex-dividend payment date |
| Spirax-Sarco Engineering PLC | ex-dividend payment date |
| Strategic Equity Capital PLC | ex-dividend payment date |
| Supermarket Income REIT PLC | ex-dividend payment date |
| Taylor Wimpey PLC | ex-dividend payment date |
| Tesco PLC | ex-dividend payment date |
| TT Electronics PLC | dividend payment date |
| WPP PLC | ex-dividend payment date |
| XP Power Ltd | dividend payment date |
| Copyright 2023 Alliance News Ltd. All Rights Reserved. | |
GSK PLC - London-based pharmaceutical company - On Monday, announces that the UK Medicines & Health Products Regulatory Agency has authorised a new indication for Jemperli, also known as dostarlimab. The drug is used as a treatment for some types of endometrial cancer and an be used to treat patients that have a tumour abnormality called mismatch repair deficient/microsatellite instability-high when the cancer is at an advanced stage when first diagnosed or has returned after previous treatment. It is now authorised to be used together with chemotherapy to slow the progression of these cancers. GSK says it is the first medicine licensed as first line treatment for primary advanced or recurrent endometrial cancer.
Read more
Last checked at